RAMAZZOTTI DANIELE

Crippa, V., Cordani, N., Villa, A., Malighetti, F., Villa, M., Sala, L., et al. (2025). Author Correction: Integrative analysis of KEAP1/NFE2L2 alterations across 3600+ tumors reveals an NRF2 expression signature as a prognostic biomarker in cancer (npj Precision Oncology, (2025), 9, 1, (291), 10.1038/s41698-025-01088-0) [Altro] [10.1038/s41698-025-01114-1]. Dettaglio

Villa, M., Malighetti, F., De, S., Villa, A., Cordani, N., Aroldi, A., et al. (2025). Comprehensive analysis of mutational processes across 20 000 adult and pediatric tumors. NUCLEIC ACIDS RESEARCH, 53(13 (22 July 2025)) [10.1093/nar/gkaf648]. Dettaglio

Civettini, I., Zappaterra, A., Corti, P., Messina, A., Aroldi, A., Biondi, A., et al. (2025). Hb Monza: A novel extensive HBB duplication with preserved α-β subunit interaction and unstable hemoglobin phenotype. MED, 6(4) [10.1016/j.medj.2024.11.007]. Dettaglio

Villa, M., Cazzaniga, G., Bolognesi, M., Malighetti, F., Crippa, V., Aroldi, A., et al. (2025). Integrative multi-omics analysis enables a comprehensive characterization of prostate cancer and unveils metastasis-associated candidate biomarkers. HELIYON, 11(12 (July 2025)) [10.1016/j.heliyon.2025.e43533]. Dettaglio

Ellrott, K., Wong, C., Yau, C., Castro, M., Lee, J., Karlberg, B., et al. (2025). Classification of non-TCGA cancer samples to TCGA molecular subtypes using compact feature sets. CANCER CELL, 43(2), 195-212.e11 [10.1016/j.ccell.2024.12.002]. Dettaglio